Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Capital Markets

<ul><li>Nike's strong set of results re-emphasized its strong competitive positioning and market leadership in its domain as the company saw a staggering 95% growth in the fourth quarter and a 19% growth for the fiscal year.</li><li>The company witnessed a broad-based growth in Q4, led by North America at more than 140%.</li><li>Overall, we are optimistic about Nike's growth strategy and give it an ‘Outperform’ rating with a revised target price.</li></ul>

Nike's strong set of results re-emphasized its strong competitive positioning and market leadership in its domain as the company saw a staggering 95% growth in the fourth quarter and a 19% growth for the fiscal year.The company witnessed a broad-based growth in Q4, led by North America at more than 140%.Overall, we are optimistic about Nike's growth strategy and give it an ‘Outperform’ rating with a revised target price.

Nike Inc Investment Thesis, Key Drivers, Financial & Price Forecasts, DCF Valuation 10/21

Equity Analyst, LightStream Research

Oshadhi Kumarasiri

Equity Analyst

Long-Short Analysis on Japan, Asia and the World

LightStream Research

LightStream conducts quantitatively rigorous and data-driven analysis with a focus on Japan and Asia.

We consistently cover the Tech, Consumer and Industrial sectors, and provide ECM and Events coverage more broadly.

We supplement traditional qualitative insights from company relationships with a robust quantitative foundation that examines as much historical data as is available.
We further refine the accuracy of our insights and calls through the use of alternative data to flesh out current trends, and through a valuation framework that emphasises non-superficial peer group selection and a proper attempt to understand the metrics and changes that have driven security valuations in the past.

Equity Bottom-Up

<ul>
<li>After growing at around 7% over 2012-19, China’s GDP growth dipped to 2.3% in 2020 due to COVID-19. The World Bank estimates the GDP growth to bounce back to 8.4% in 2021 but projects a rapid deceleration (5.4% in 2022) thereafter due to multiple economic headwinds.</li>
<li>We think that the Chinese sportswear market is highly influenced by the GDP growth as it declined at an annual average rate of 2% during 2011-13 when the GDP growth decelerated from 9.6% to 7.8%.</li>
</ul>


After growing at around 7% over 2012-19, China’s GDP growth dipped to 2.3% in 2020 due to COVID-19. The World Bank estimates the GDP growth to bounce back to 8.4% in 2021 but projects a rapid deceleration (5.4% in 2022) thereafter due to multiple economic headwinds.
We think that the Chinese sportswear market is highly influenced by the GDP growth as it declined at an annual average rate of 2% during 2011-13 when the GDP growth decelerated from 9.6% to 7.8%.


Chinese Sportswear: Macro Headwinds Pose Significant Downside Risks

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical and Quantitative Research

Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical Analysis

<p>We continue to see a mixed market, and weak market dynamics lead us to be cautious. One of the primary issues is weak breadth; the large-cap indexes (S&amp;P 500 and Nasdaq) remain bullish despite being held up by a relatively small number of mega-cap growth stocks, a condition that can persist for weeks or months. Ultimately, as long as there continues to be an absence of breakdowns at the index and Sector level we remain constructive overall.</p>

We continue to see a mixed market, and weak market dynamics lead us to be cautious. One of the primary issues is weak breadth; the large-cap indexes (S&amp;P 500 and Nasdaq) remain bullish despite being held up by a relatively small number of mega-cap growth stocks, a condition that can persist for weeks or months. Ultimately, as long as there continues to be an absence of breakdowns at the index and Sector level we remain constructive overall.

U.S. Equity Strategy: Cautious Overall; Favor Large-Caps & Growth; Key Supports Holding In The U.S.

<ul><li>Nike reported a jaw-dropping financial result stunning all of Wall Street after reporting a staggering 96% year-on-year growth in its top-line.</li><li>Nike is also gradually reducing its dependence on retailers like Foot Locker as well as distributors by boosting its direct-to-consumer business which should account for as much as 60% of the company’s top-line by 2025.</li><li>In this report, we have carried out a fundamental analysis of the historical financial statements of the company.</li></ul>

Nike reported a jaw-dropping financial result stunning all of Wall Street after reporting a staggering 96% year-on-year growth in its top-line.Nike is also gradually reducing its dependence on retailers like Foot Locker as well as distributors by boosting its direct-to-consumer business which should account for as much as 60% of the company’s top-line by 2025.In this report, we have carried out a fundamental analysis of the historical financial statements of the company.

Nike Inc Investment Thesis, Key Drivers, Financial & Price Forecasts, DCF Valuation

Latest News from the World’s Leading Innovators

Granite Bay Capital

An innovation focussed investment company

Granite Bay Capital is an innovation focussed investment company with a deep focus on the companies at the leading edge of innovation across major themes such as AI, ubiquitous computing, sustainability, automation and longevity.

Thematic (Sector/Industry)

<p>Headline Developments: We can now modify DNA inside of a human body (in vivo), thanks to some groundbreaking work announced this week by Intellia Therapeutics (NTLA) which saw the company’s share price surge 55%.  What this means is that we can now send precision therapeutics (based on CRISPR technology) to “seek and destroy” problematic genes.</p>

Headline Developments: We can now modify DNA inside of a human body (in vivo), thanks to some groundbreaking work announced this week by Intellia Therapeutics (NTLA) which saw the company’s share price surge 55%.  What this means is that we can now send precision therapeutics (based on CRISPR technology) to “seek and destroy” problematic genes.

United States

NIKE, Inc. designs, develops, and markets athletic footwear, apparel, equipment, and accessory products for men, women, and children. The Company sells its products worldwide to retail stores, through its own stores, subsidiaries, and distributors.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Nike (NKE US)

Nike Inc Investment Thesis, Key Drivers, Financial & Price Forecasts, DCF Valuation 10/21

Nike's strong set of results re-emphasized its strong competitive positioning and market leadership in its domain as the company saw a staggering...

Baptista Research

Chinese Sportswear: Macro Headwinds Pose Significant Downside Risks

The Chinese sportswear market is highly influenced by the GDP growth as it declined at an annual average rate of 2% during 2011-13 when the GDP...

Oshadhi Kumarasiri

U.S. Equity Strategy: Cautious Overall; Favor Large-Caps & Growth; Key Supports Holding In The U.S.

The S&P 500 remains bullish, recently hitting our 4400-4406 target as large-caps remain attractive. As long as support at the 50-day MA and 4257...

Vermilion Research

Nike Inc Investment Thesis, Key Drivers, Financial & Price Forecasts, DCF Valuation

Nike reported a jaw-dropping financial result stunning all of Wall Street after reporting a staggering 96% year-on-year growth in its...

Baptista Research

Weekly Innovation Review (WIRE) #38

Headline Developments: We can now modify DNA inside of a human body (in vivo), thanks to some groundbreaking work announced this week

Granite Bay Capital

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)